Geneticlines

A biobank that aims to gain more knowledge about the origin and treatment of (hereditary) diseases Cohort
A biobank that aims to gain more knowledge about the origin and treatment of (hereditary) diseases
Research into genetic disorders is complex and often requires a lot of information. To find out which changes in DNA are normal and which may cause a disease, it is necessary to compare DNA from sick and healthy people.

The GeneticLines biobank started in 2021 and prospectively collects phenotype information, biomaterials and genetic data from patients. With the data from Geneticlines, scientists can research the origin and treatment of (hereditary) diseases. 

  • At the moment, all patients (>18 years) that visit our policlinics are prospectively included. In the near future, children will be included as well.  


  • GeneticLines prospectively collects phenotype information, biomaterials and genetic data from patients, such as:

    • general patient information (e.g. gender, date of birth); 
    • clinical history (e.g., phenotypes, comorbidities, family history; 
    • genetic data 
    • DNA, RNA, serum, plasma, whole blood.

  • Please visit Geneticlines for more information about patient participation (in Dutch).


Relevance

How Geneticlines benefits to society

The discovery of the genetic origins of diseases allows prediction of the chance of occurrence of disorders that are (partly) genetically determined, so that preventive and therapeutic measures can be offered in a more targeted way. In addition, it will increasingly be possible to identify the sensitivity to (side effects of) medicines and to prescribe tailor-made medication. 

Contact

Cleo van Diemen
Cleo van Diemen Postdoc researcher

University Medical Center Groningen (UMCG)
Geneticlines
PO Box 30.001
9700 RB Groningen
The Netherlands

Visiting address
University Medical Center Groningen (UMCG)
UMCG Department Genetics
Antonius Deusinglaan 1
9713 AV Groningen

More information visite our website